163 related articles for article (PubMed ID: 38169774)
21. Evolution of the holozoan ribosome biogenesis regulon.
Brown SJ; Cole MD; Erives AJ
BMC Genomics; 2008 Sep; 9():442. PubMed ID: 18816399
[TBL] [Abstract][Full Text] [Related]
22. CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis.
Mohapatra P; Mohanty S; Ansari SA; Shriwas O; Ghosh A; Rath R; Majumdar SKD; Swain RK; Raghav SK; Dash R
FASEB J; 2022 Oct; 36(10):e22566. PubMed ID: 36165231
[TBL] [Abstract][Full Text] [Related]
23. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C
BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779
[TBL] [Abstract][Full Text] [Related]
24. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
[TBL] [Abstract][Full Text] [Related]
25. HSPC111 governs breast cancer growth by regulating ribosomal biogenesis.
Zhang C; Yin C; Wang L; Zhang S; Qian Y; Ma J; Zhang Z; Xu Y; Liu S
Mol Cancer Res; 2014 Apr; 12(4):583-94. PubMed ID: 24425784
[TBL] [Abstract][Full Text] [Related]
26. The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.
Yao Q; He L; Gao X; Tang N; Lin L; Yu X; Wang D
Front Oncol; 2021; 11():699749. PubMed ID: 34476213
[TBL] [Abstract][Full Text] [Related]
27. Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT.
Chen K; Xu J; Tong YL; Yan JF; Pan Y; Wang WJ; Zheng L; Zheng XX; Hu C; Hu X; Shen X; Chen W
Cell Death Dis; 2023 Feb; 14(2):115. PubMed ID: 36781842
[TBL] [Abstract][Full Text] [Related]
28. Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma.
Devlin JR; Hannan KM; Hein N; Cullinane C; Kusnadi E; Ng PY; George AJ; Shortt J; Bywater MJ; Poortinga G; Sanij E; Kang J; Drygin D; O'Brien S; Johnstone RW; McArthur GA; Hannan RD; Pearson RB
Cancer Discov; 2016 Jan; 6(1):59-70. PubMed ID: 26490423
[TBL] [Abstract][Full Text] [Related]
29. RRP15 deficiency induces ribosome stress to inhibit colorectal cancer proliferation and metastasis via LZTS2-mediated β-catenin suppression.
Dong Z; Li J; Dai W; Yu D; Zhao Y; Liu S; Li X; Zhang Z; Zhang R; Liang X; Kong Q; Jin S; Jiang H; Jiang W; Ding C
Cell Death Dis; 2023 Feb; 14(2):89. PubMed ID: 36750557
[TBL] [Abstract][Full Text] [Related]
30. A positive feedback loop between EBP2 and c-Myc regulates rDNA transcription, cell proliferation, and tumorigenesis.
Liao P; Wang W; Shen M; Pan W; Zhang K; Wang R; Chen T; Chen Y; Chen H; Wang P
Cell Death Dis; 2014 Jan; 5(1):e1032. PubMed ID: 24481446
[TBL] [Abstract][Full Text] [Related]
31. The in vivo functions of ARPF2 and ARRS1 in ribosomal RNA processing and ribosome biogenesis in Arabidopsis.
Choi I; Jeon Y; Yoo Y; Cho HS; Pai HS
J Exp Bot; 2020 May; 71(9):2596-2611. PubMed ID: 32275312
[TBL] [Abstract][Full Text] [Related]
32. Nucleolar stress: From development to cancer.
Lafita-Navarro MC; Conacci-Sorrell M
Semin Cell Dev Biol; 2023 Feb; 136():64-74. PubMed ID: 35410715
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
34. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
35. Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth.
Zisi A; Kanellis DC; Moussaud S; Karlsson I; Carén H; Bräutigam L; Bartek J; Lindström MS
Neuro Oncol; 2023 Jun; 25(6):1058-1072. PubMed ID: 36583853
[TBL] [Abstract][Full Text] [Related]
36. NORAD-sponged miR-378c alleviates malignant behaviors of stomach adenocarcinoma via targeting NRP1.
Hu Y; Luo M
Cancer Cell Int; 2022 Feb; 22(1):79. PubMed ID: 35164743
[TBL] [Abstract][Full Text] [Related]
37. Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex.
Liao JM; Zhou X; Gatignol A; Lu H
Oncogene; 2014 Oct; 33(41):4916-23. PubMed ID: 24141778
[TBL] [Abstract][Full Text] [Related]
38. Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndrome.
Tremblay MG; Sibai DS; Valère M; Mars JC; Lessard F; Hori RT; Khan MM; Stefanovsky VY; LeDoux MS; Moss T
PLoS Genet; 2022 Feb; 18(2):e1009644. PubMed ID: 35139074
[TBL] [Abstract][Full Text] [Related]
39. p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways.
Lindström MS; Bartek J; Maya-Mendoza A
Cell Death Differ; 2022 May; 29(5):972-982. PubMed ID: 35444234
[TBL] [Abstract][Full Text] [Related]
40. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
